DIVISLAB · Divi's Laboratories Limited · Financials
Volume · Nov 12
25.63K
Avg daily vol (3M)
37.42K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
105.6B
+12.8%
FY2026
Net Income
25.68B
+17.2%
FY2026
Operating Cash Flow
27.38B
+65.6%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|---|
| INR | 121.91B | 105.6B | 93.6B | 78.45B | 77.68B | 89.6B | 69.69B | 53.94B |
| INR | 5.13B | 4.63B | 4.02B | 3.78B | 3.43B | 3.12B | 2.56B | 1.86B |
| INR | 310M | 230M | 20M | 30M | 6.7M | 8M | 8.7M | 61M |
| INR | 44.28B | 33.88B | 29.16B | 21.63B | 23.69B | 36.84B | 26.66B | 18.19B |
| INR | 10.65B | 8.2B | 7.25B | 5.63B | 5.45B | 7.23B | 6.82B | 4.43B |
| INR | 33.63B | 25.68B | 21.91B | 16B | 18.23B | 29.6B | 19.84B | 13.77B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 37.16B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.